| PYRUKYND AGIOS PHARMACEUTICALS INC
2135360 20 Jul 2021 | on 10 May 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia. | | | PYRUKYND AGIOS PHARMACEUTICALS INC.
2033295 11 Jan 2020 | on 18 Jan 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, polycystic kidney disease (PKD) and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias | | 
